Explore our complete collection of peptide guides, research, and wellness insights
FDA warning letters from March and April 2026 document specific impurity failures in compounded semaglutide, including N-acetyl semaglutide at 1.8%
Read More →FDA's 2026 guidance tightens quality standards for compounded tirzepatide and semaglutide, mandating FDA-approved APIs, banning unapproved salt
Read More →Ozari Health advertises compounded semaglutide for $86 and tirzepatide for $125, but new 2026 GLP-1 data and FDA enforcement actions reveal hidden
Read More →FDA's subpotent tirzepatide findings are reshaping oversight. Here's how those quality failures could trigger targeted semaglutide inspections at
Read More →FDA's new draft guidance excludes tirzepatide and semaglutide from bulk compounding, potentially ending most compounded GLP-1 access. Here's what
Read More →FTC warning letters target compounded tirzepatide and semaglutide ads that omit prescription status or imply FDA approval. Sellers face fines up to
Read More →An FDA panel vote on six peptides could limit compounded tirzepatide and semaglutide for alcohol craving studies. Researchers face higher costs and
Read More →FDA panel vote on six peptides could limit compounded tirzepatide for VA alcohol trial. Learn how BPC-157, MK-677, Semax, and Hexarelin decisions
Read More →FDA panel vote on six peptides sets a precedent for semaglutide and tirzepatide compounding rules. Safety data and shortage status will drive future
Read More →An FDA advisory panel voted on six peptides, including BPC-157 and MK-677, signaling tighter compounding rules that could limit access to tirzepatide
Read More →An FDA panel vote on tirzepatide compounding access could reshape GLP-1 availability. Learn what the decision means for researchers and patients amid
Read More →FDA testing finds subpotent tirzepatide in compounded formulations as GLP-1 shortages resolve. The findings shift regulatory enforcement, pharmacy
Read More →FDA investigates compounded tirzepatide after a 2024 study finds sterility and potency issues. The probe may reshape access to GLP-1 drugs and affect
Read More →FDA warnings on compounded semaglutide target online sourcing. Learn how new rules affect tirzepatide, BPC-157, MK-677, and research supply chains.
Read More →
Thymosin Alpha-1 is a naturally occurring peptide that has gained significant attention in the wellness community for its potential role in support...
Read More →
The immune system is one of the body's most sophisticated defense mechanisms, constantly working to protect us from pathogens, infections, and dise...
Read More →